Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B.

Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM.

Kaohsiung J Med Sci. 2015 Sep;31(9):445-53. doi: 10.1016/j.kjms.2015.07.002. Epub 2015 Aug 21.

2.

Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals.

Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance--Monitoring Study TASER-M.

J Med Virol. 2016 Feb;88(2):234-43. doi: 10.1002/jmv.24320. Epub 2015 Jul 17.

3.

Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.

Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.

Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19.

4.

Comparison of Xpert MTB/RIF Assay and the Conventional Sputum Microscopy in Detecting Mycobacterium tuberculosis in Northern Thailand.

Pinyopornpanish K, Chaiwarith R, Pantip C, Keawvichit R, Wongworapat K, Khamnoi P, Supparatpinyo K, Sirisanthana T.

Tuberc Res Treat. 2015;2015:571782. doi: 10.1155/2015/571782. Epub 2015 Apr 30.

5.

Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia.

Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A; TREAT Asia Studies to Evaluate Resistance-Monitoring (TASER-M) Database.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. doi: 10.1097/QAI.0000000000000614. No abstract available.

6.

Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database.

AIDS Patient Care STDS. 2015 May;29(5):229-31. doi: 10.1089/apc.2014.0232. Epub 2015 Mar 16. No abstract available.

7.

Transmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007-2010) - TASER-S.

Jiamsakul A, Sirivichayakul S, Ditangco R, Wong KH, Li PC, Praparattanapan J, Phanuphak P, Segubre-Mercado E, Yam WC, Sirisanthana T, Singtoroj T, Law M; TREAT Asia Studies to Evaluate Resistance – Surveillance Study (TASER-S).

AIDS Res Ther. 2015 Feb 13;12:3. doi: 10.1186/s12981-015-0043-1. eCollection 2015.

9.

Factors associated with suboptimal adherence to antiretroviral therapy in Asia.

Jiamsakul A, Kumarasamy N, Ditangco R, Li PC, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, K C Lee C, Mustafa M, Merati T, Kamarulzaman A, Singtoroj T, Law M; TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M).

J Int AIDS Soc. 2014 May 16;17:18911. doi: 10.7448/IAS.17.1.18911. eCollection 2014.

10.

Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.

Phanuphak P, Sirivichayakul S, Jiamsakul A, Sungkanuparph S, Kumarasamy N, Lee MP, Sirisanthana T, Kantipong P, Lee C, Kamarulzaman A, Mustafa M, Ditangco R, Merati T, Ratanasuwan W, Singtoroj T, Kantor R.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):74-9. doi: 10.1097/QAI.0000000000000108.

11.

Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.

Guy R, Wand H, McManus H, Vonthanak S, Woolley I, Honda M, Read T, Sirisanthana T, Zhou J, Carr A; Australia HIV Observational Database (AHOD) and Treat Asia HIV Observation Database (TAHOD).

AIDS Patient Care STDS. 2013 Dec;27(12):681-91. doi: 10.1089/apc.2012.0439.

12.

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.

Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific HIV Observational Database (APHOD).

PLoS One. 2013 Jun 28;8(6):e64902. doi: 10.1371/journal.pone.0064902. Print 2013.

13.

Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.

Dokuta S, Utaipat U, Praparattanapan J, Keitkarn J, Maneekarn N, Sirisanthana T, Supparatpinyo K.

J Virol Methods. 2013 Jun;190(1-2):20-8. doi: 10.1016/j.jviromet.2013.03.016. Epub 2013 Apr 3.

PMID:
23562659
14.
15.

Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database.

Byakwaga H, Petoumenos K, Ananworanich J, Zhang F, Boyd MA, Sirisanthana T, Li PC, Lee C, Mean CV, Saphonn V, Omar SF, Pujari S, Phanuphak P, Lim PL, Kumarasamy N, Chen YM, Merati TP, Sungkanuparph S, Ditangco R, Oka S, Tau G, Zhou J, Law MG, Emery S.

J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):270-7. doi: 10.1177/1545109712469684. Epub 2013 Feb 19.

16.

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.

Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):293-300. doi: 10.1097/QAI.0b013e31827a2e8f.

17.

Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.

Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).

BMC Res Notes. 2012 Oct 24;5:582. doi: 10.1186/1756-0500-5-582.

18.

Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.

Praparattanapan J, Kotarathitithum W, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K.

Curr HIV Res. 2012 Dec;10(8):647-52.

PMID:
23061604
19.

Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand.

Limmahakhun S, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K.

Int J STD AIDS. 2012 Jun;23(6):414-8. doi: 10.1258/ijsa.2012.011291.

PMID:
22807535
20.

Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.

Achhra AC, Amin J, Hoy J, Tanuma J, Sirisanthana T, Nolan D, Merati T, Giles M.

AIDS Res Treat. 2012;2012:246280. doi: 10.1155/2012/246280. Epub 2012 May 14.

21.

Causes of first hospitalization among 1121 HIV-infected children: comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods.

Sudjaritruk T, Oberdorfer P, Puthanakit T, Sirisanthana T, Sirisanthana V.

Int J STD AIDS. 2012 May;23(5):335-9. doi: 10.1258/ijsa.2012.011203.

PMID:
22648887
22.

Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand.

Praparattanapan J, Kotarathitithum W, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K, Tragoolpua Y.

Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):859-66.

PMID:
22299468
23.

Epidemiology of adult candidemia at Chiang Mai University Hospital.

Chaiwarith R, Ounbang P, Khamwan C, Nuntachit N, Sirisanthana T, Supparatpinyo K.

Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1505-14.

PMID:
22299422
24.

Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.

Sudjaritruk T, Sirisanthana T, Sirisanthana V.

BMC Infect Dis. 2012 Jan 31;12:28. doi: 10.1186/1471-2334-12-28. Review.

25.

Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.

Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database.

J Int AIDS Soc. 2012 Jan 26;15(1):1. doi: 10.1186/1758-2652-15-1.

26.

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Aurpibul L, Puthanakit T, Taejaroenkul S, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2012 Apr;31(4):384-8. doi: 10.1097/INF.0b013e31823f0e11.

PMID:
22124211
27.

Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand.

Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K.

AIDS Res Ther. 2011 Nov 7;8(1):42. doi: 10.1186/1742-6405-8-42.

28.

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.

Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, Brinkhof MW, Mwango A, Balestre E, Carriquiry G, Sirisanthana T, Mukumbi H, Martin JN, Grimsrud A, Bacon M, Thiebaut R; International Epidemiologic Databases to Evaluate AIDS Collaboration.

PLoS Med. 2011 Oct;8(10):e1001111. doi: 10.1371/journal.pmed.1001111. Epub 2011 Oct 25.

29.

Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand.

Chaiwarith R, Fakthongyoo A, Praparattanapan J, Boonmee D, Sirisanthana T, Supparatpinyo K.

Curr HIV Res. 2011 Jul;9(5):334-8.

PMID:
21916838
30.

Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.

Phongsamart W, Sirisanthana V, Wittawatmongkol O, Maleesatharn A, Sudjaritruk T, Chearskul P, Aurpibul L, Sirisanthana T, Chokephaibulkit K.

Vaccine. 2011 Nov 3;29(47):8705-11. doi: 10.1016/j.vaccine.2011.08.101. Epub 2011 Sep 3.

PMID:
21893147
31.

Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.

Chaiwarith R, Jullaket W, Bunchoo M, Nuntachit N, Sirisanthana T, Supparatpinyo K.

BMC Infect Dis. 2011 May 25;11:149. doi: 10.1186/1471-2334-11-149.

32.

Clinical study concerning the relationship between community-acquired pneumonia and viral infection in northern Thailand.

Hara K, Yahara K, Gotoh K, Nakazono Y, Kashiwagi T, Imamura Y, Hamada N, Khositsakulchai W, Sanchai T, Khantawa B, Tharavichitkul P, Maneekarn N, Sirisanthana T, Watanabe H.

Intern Med. 2011;50(9):991-8. Epub 2011 May 1.

33.

Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).

Han SH, Zhou J, Saghayam S, Vanar S, Phanuphak N, Chen YM, Sirisanthana T, Sungkanuparph S, Lee CK, Pujari S, Li PC, Oka S, Saphonn V, Zhang F, Merati TP, Law MG, Choi JY; TREAT Asia HIV Observational Database.

Endocr J. 2011;58(6):475-84. Epub 2011 Apr 27.

34.

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.

Lao-Araya M, Puthanakit T, Aurpibul L, Taecharoenkul S, Sirisanthana T, Sirisanthana V.

Vaccine. 2011 May 23;29(23):3977-81. doi: 10.1016/j.vaccine.2011.03.077. Epub 2011 Apr 5.

PMID:
21473954
35.

HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M).

Clin Infect Dis. 2011 Apr 15;52(8):1053-7. doi: 10.1093/cid/cir107.

36.

Current molecular epidemiology and recombination of HIV type 1 subtypes in northern Thailand.

Praparattanapan J, Tragoolpua Y, Pathom-aree W, Kotarathitithum W, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1201-6. doi: 10.1089/AID.2010.0257. Epub 2011 May 6.

PMID:
21449850
37.

Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy.

Chaiwarith R, Praparattanapan J, Nuntachit N, Kotarathitithum W, Sirisanthana T, Supparatpinyo K.

Curr HIV Res. 2011 Mar;9(2):82-7.

PMID:
21361862
38.

Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.

Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YM, Han N, Lim PL, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S, Kamarulzaman A, Phanuphak P, Lee CK, Li PC, Pujari S, Saphonn V, Law MG.

BMC Infect Dis. 2010 Dec 23;10:361. doi: 10.1186/1471-2334-10-361.

39.

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance.

Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10. No abstract available.

40.

Antibody responses to hepatitis A virus vaccination in thai hiv-infected children with immune recovery after antiretroviral therapy.

Sudjaritruk T, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2011 Mar;30(3):256-9. doi: 10.1097/INF.0b013e3181f812f8.

PMID:
20856163
41.

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine.

Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V.

Vaccine. 2010 Aug 16;28(36):5900-2. doi: 10.1016/j.vaccine.2010.06.048. Epub 2010 Jun 29.

PMID:
20600498
42.

Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific Region.

Pujari S, Srasuebkul P, Sungkanuparph S, Lim PL, Kumarasamy N, Chuah J, Kumar RN, Chen YM, Oka S, Choi JY, Lee MP, Phanuphak P, Kamarulzaman A, Lee C, Fujie Z, Ditangco R, Saphonn V, Sirisanthana T, Merati TP, Smith J, Law MG.

J Antivir Antiretrovir. 2009 Nov 1;1(1):28-35.

43.

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy.

Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V.

Clin Infect Dis. 2010 May 15;50(10):1415-8. doi: 10.1086/652150.

PMID:
20377409
44.

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, Sirisanthana T, Chen YM, Pujari S, Kumarasamy N, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; TREAT Asia HIV Observational Database.

HIV Med. 2010 Sep;11(8):519-29. doi: 10.1111/j.1468-1293.2010.00822.x. Epub 2010 Mar 21.

45.

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Aurpibul L, Puthanakit T, Taecharoenkul S, Sirisanthana T, Sirisanthana V.

AIDS Patient Care STDS. 2009 Dec;23(12):1067-71. doi: 10.1089/apc.2009.0093.

PMID:
19909170
46.

Measles outbreak in an orphanage: HIV-infected children on antiretroviral therapy are still at risk.

Aurpibul L, Puthanakit T, Kanjanavanit S, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2010 Feb;29(2):167-9. doi: 10.1097/INF.0b013e3181b99e15.

PMID:
19907357
47.

Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions.

Sakkhachornphop S, Jiranusornkul S, Kodchakorn K, Nangola S, Sirisanthana T, Tayapiwatana C.

Protein Sci. 2009 Nov;18(11):2219-30. doi: 10.1002/pro.233.

48.

Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).

Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YM, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Omar SF, Lee CK, Ditangco R, Merati TP, Lim PL, Choi JY, Law MG, Pujari S; TREAT Asia HIV Observational Database.

HIV Med. 2010 Jan;11(1):31-9. doi: 10.1111/j.1468-1293.2009.00738.x. Epub 2009 Jul 6.

49.

Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count.

Chaiwarith R, Salee P, Kotarathitithum W, Sirisanthana T, Supparatpinyo K.

Curr HIV Res. 2009 May;7(3):340-5.

PMID:
19442132
50.

Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.

Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R.

BMC Infect Dis. 2009 Apr 21;9:46. doi: 10.1186/1471-2334-9-46.

Supplemental Content

Loading ...
Support Center